Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
Defective Angiogenesis in Mice Lacking Endoglin
1999 • 851 citations
Role of angiogenesis in patients with cerebral ischemic stroke.
1994 • 820 citations
Genetic control of the circulating concentration of transforming growth factor type beta1
1999 • 749 citations
Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
1997 • 715 citations
Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels
1997 • 356 citations
Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis.
1999 • 340 citations
Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy.
1995 • 334 citations
Endoglin modulates cellular responses to TGF-beta 1.
1996 • 306 citations
Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients
1997 • 288 citations
Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours
1994 • 234 citations
Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients.
1998 • 220 citations
Transforming Growth Factor-β: Latent Forms, Binding Proteins and Receptors
1993 • 215 citations
Elevated Plasma Transforming Growth Factor-β1 Levels in Breast Cancer Patients Decrease After Surgical Removal of the Tumor
1995 • 207 citations
A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues
1993 • 186 citations
Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells.
1997 • 175 citations
TGF-β singaling and cancer: structural and functional consequences of mutations in Smads
1998 • 160 citations
Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies.
1999 • 140 citations
EDITORIAL. CD105 AND ANGIOGENESIS
1996 • 134 citations
Breast Carcinoma: Comparative Study of Tummor Vasculature Using Two Endothelial Cell Markers
1994 • 127 citations
Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer
1998 • 106 citations
TGF-?1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis
1999 • 103 citations
Active and acid-activatable TGF-β in human sera, platelets and plasma
1995 • 93 citations
Relationship of transforming growth factor β1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma
1994 • 90 citations
Serum basic fibroblast growth factor in men with and without prostate carcinoma
1995 • 73 citations
Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments
1997 • 63 citations
Irradiation induces Up‐regulation of E9 protein (CD105) in human vascular endothelial cells
1995 • 58 citations
Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy.
1998 • 40 citations
Regulation and Role of TGFβ Production in Breast Cancera
1996 • 36 citations
Prognostic significance of TGF-beta 1 and TGF-beta 2 expressions in female breast cancer.
1995 • 27 citations
Immunodetection and characterisation of soluble CD105-TGFβ complexes
1998 • 23 citations